{"entity":{"type":"insider","cik":"0001896056","url":"/insider/0001896056","json_url":"/insider/0001896056.json","name":"Shemesh Shay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":12,"first":"2022-02-08","last":"2024-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Shemesh Shay","source":"filing","n_filings":12,"first_seen":"2022-02-08","last_seen":"2024-05-13"}],"transactions":[{"id":3040734,"accession":"0001104659-24-060261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-060261","line_url":"/filing/0001104659-24-060261#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1113.0,"shares_display":"1,113","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":7034.16,"total_display":"7,034.16","total_whole":"7,034","shares_owned_after":1493068.0,"shares_owned_after_display":"1,493,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-13","scope":"insider"},{"id":7924826,"accession":"0001104659-23-035392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-035392","line_url":"/filing/0001104659-23-035392#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":420.0,"shares_display":"420","price_per_share":11.99,"price_display":"11.99","price_state":"stated","total_value":5035.8,"total_display":"5,035.80","total_whole":"5,036","shares_owned_after":1361955.0,"shares_owned_after_display":"1,361,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-22","scope":"insider"},{"id":8586189,"accession":"0001104659-23-033594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-033594","line_url":"/filing/0001104659-23-033594#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":670.0,"shares_display":"670","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":7175.7,"total_display":"7,175.70","total_whole":"7,176","shares_owned_after":1361535.0,"shares_owned_after_display":"1,361,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider"},{"id":6323046,"accession":"0001104659-22-129348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-129348","line_url":"/filing/0001104659-22-129348#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":3825.0,"total_display":"3,825.00","total_whole":"3,825","shares_owned_after":1245865.0,"shares_owned_after_display":"1,245,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6476565,"accession":"0001104659-22-120080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-120080","line_url":"/filing/0001104659-22-120080#line-2","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":1080.0,"total_display":"1,080.00","total_whole":"1,080","shares_owned_after":1245365.0,"shares_owned_after_display":"1,245,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-18","scope":"insider"},{"id":6476562,"accession":"0001104659-22-120080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-120080","line_url":"/filing/0001104659-22-120080#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":1065.0,"total_display":"1,065.00","total_whole":"1,065","shares_owned_after":1245215.0,"shares_owned_after_display":"1,245,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6307758,"accession":"0001104659-22-103166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-103166","line_url":"/filing/0001104659-22-103166#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":220.0,"shares_display":"220","price_per_share":7.87,"price_display":"7.87","price_state":"stated","total_value":1731.4,"total_display":"1,731.40","total_whole":"1,731","shares_owned_after":1245065.0,"shares_owned_after_display":"1,245,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-27","scope":"insider"},{"id":6702180,"accession":"0001104659-22-097692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-097692","line_url":"/filing/0001104659-22-097692#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":404.0,"shares_display":"404","price_per_share":8.31,"price_display":"8.31","price_state":"stated","total_value":3357.24,"total_display":"3,357.24","total_whole":"3,357","shares_owned_after":1244845.0,"shares_owned_after_display":"1,244,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6214909,"accession":"0001104659-22-097216","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-097216","line_url":"/filing/0001104659-22-097216#line-2","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1530.0,"shares_display":"1,530","price_per_share":8.07,"price_display":"8.07","price_state":"stated","total_value":12347.1,"total_display":"12,347.10","total_whole":"12,347","shares_owned_after":1244441.0,"shares_owned_after_display":"1,244,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-02","scope":"insider"},{"id":6214904,"accession":"0001104659-22-097216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-097216","line_url":"/filing/0001104659-22-097216#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1476.0,"shares_display":"1,476","price_per_share":8.07,"price_display":"8.07","price_state":"stated","total_value":11911.32,"total_display":"11,911.32","total_whole":"11,911","shares_owned_after":1242911.0,"shares_owned_after_display":"1,242,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-31","filed_date":"2022-09-02","scope":"insider"},{"id":6990725,"accession":"0001104659-22-063644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-063644","line_url":"/filing/0001104659-22-063644#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":16.54,"price_display":"16.54","price_state":"stated","total_value":4962.0,"total_display":"4,962.00","total_whole":"4,962","shares_owned_after":1241435.0,"shares_owned_after_display":"1,241,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6990695,"accession":"0001104659-22-062271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-062271","line_url":"/filing/0001104659-22-062271#line-2","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142.0,"shares_display":"142","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":2776.1,"total_display":"2,776.10","total_whole":"2,776","shares_owned_after":1241135.0,"shares_owned_after_display":"1,241,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-18","scope":"insider"},{"id":6990692,"accession":"0001104659-22-062271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-062271","line_url":"/filing/0001104659-22-062271#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":19.28,"price_display":"19.28","price_state":"stated","total_value":1928.0,"total_display":"1,928.00","total_whole":"1,928","shares_owned_after":1240993.0,"shares_owned_after_display":"1,240,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":6366051,"accession":"0001104659-22-059890","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-059890","line_url":"/filing/0001104659-22-059890","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Dev. & Ops. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Ops. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Ops. Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1278.0,"shares_display":"1,278","price_per_share":15.848716744913927,"price_display":"15.85","price_state":"stated","total_value":20254.66,"total_display":"20,254.66","total_whole":"20,255","shares_owned_after":1240835.0,"shares_owned_after_display":"1,240,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-13","scope":"insider","n_lines":3},{"id":6808942,"accession":"0001104659-22-014375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-014375","line_url":"/filing/0001104659-22-014375#line-2","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.00001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":846.0,"shares_display":"846","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":2935.62,"total_display":"2,935.62","total_whole":"2,936","shares_owned_after":1179615.0,"shares_owned_after_display":"1,179,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-08","scope":"insider"},{"id":6808936,"accession":"0001104659-22-014375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-014375","line_url":"/filing/0001104659-22-014375#line-1","is_derivative":false,"issuer_cik":"0001875558","issuer_name":"Nuvectis Pharma, Inc.","issuer_ticker":"NVCT","issuer_name_source":null,"issuer_url":"/issuer/0001875558","owner_cik":"0001896056","owner_name":"Shemesh Shay","owner_display_name":"Shemesh Shay","owner_url":"/insider/0001896056","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock, par value $0.00001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":3.38,"price_display":"3.38","price_state":"stated","total_value":7098.0,"total_display":"7,098.00","total_whole":"7,098","shares_owned_after":1178769.0,"shares_owned_after_display":"1,178,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001875558","name":"Nuvectis Pharma, Inc.","url":"/issuer/0001875558","role":"Officer (Chief Dev. & Ops. Officer)","n_filings":12,"first_seen":"2022-02-08","last_seen":"2024-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001896056","retrieved_at":"2026-08-24T15:02:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}